Brentuximab Vedotin in Advanced Hodgkin’s Lymphoma
Brentuximab Vedotin in Advanced Hodgkin’s Lymphoma
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
To the Editor:
For all studies of frontline therapy in which data on overall survival are provided, such as in the ECHELON-1 trial reported on by Ansell et al. (July 28 issue),
1
it is imperative to have clear reporting of postprotocol therapies and full transparency with regard to trial results so that readers can better interpret the fin...
Alternative Titles
Full title
Brentuximab Vedotin in Advanced Hodgkin’s Lymphoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2726464122
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2726464122
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc2211125
